American Portfolios Advisors Cara Therapeutics, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 40,425 shares of CARA stock, worth $12,936. This represents 0.02% of its overall portfolio holdings.

Number of Shares
40,425
Holding current value
$12,936
% of portfolio
0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$8.24 - $12.56 $333,102 - $507,738
40,425 New
40,425 $378 Million
Q1 2022

Mar 21, 2023
BUY
$9.94 - $12.65 $4,970 - $6,325
500 Added 1.24%
40,925 $497 Million
Q4 2021

Mar 21, 2023
BUY
$11.99 - $18.14 $7,194 - $10,884
600 Added 1.48%
41,025 $500 Million
Q3 2021

Mar 22, 2023
BUY
$11.55 - $16.06 $9,240 - $12,847
800 Added 1.98%
41,225 $637 Million
Q2 2021

Mar 22, 2023
BUY
$12.38 - $29.19 $9,904 - $23,352
800 Added 1.98%
41,225 $588 Million
Q1 2021

Mar 22, 2023
SELL
$15.07 - $21.71 $140,151 - $201,903
-9,300 Reduced 23.01%
31,125 $676 Million
Q4 2020

Mar 22, 2023
SELL
$12.72 - $16.16 $183,168 - $232,704
-14,400 Reduced 35.62%
26,025 $394 Million
Q3 2020

Mar 22, 2023
SELL
$12.34 - $17.92 $175,228 - $254,464
-14,200 Reduced 35.13%
26,225 $334 Million
Q2 2020

Mar 24, 2023
SELL
$12.39 - $17.33 $929 - $1,299
-75 Reduced 0.29%
26,125 $447 Million
Q1 2020

Mar 24, 2023
SELL
$9.12 - $17.78 $129,731 - $252,920
-14,225 Reduced 35.19%
26,200 $346 Million
Q4 2019

Mar 24, 2023
SELL
$16.11 - $25.98 $230,775 - $372,163
-14,325 Reduced 35.44%
26,100 $420 Million
Q2 2019

Mar 24, 2023
SELL
$17.68 - $21.57 $251,498 - $306,833
-14,225 Reduced 35.19%
26,200 $563 Million
Q1 2019

Mar 24, 2023
SELL
$14.41 - $19.64 $11,528 - $15,712
-800 Reduced 40.0%
1,200 $23.5 Million
Q4 2018

Mar 24, 2023
BUY
$12.45 - $23.47 $15,251 - $28,750
1,225 Added 158.06%
2,000 $26 Million
Q3 2018

Mar 24, 2023
SELL
$17.57 - $23.95 $696,650 - $949,617
-39,650 Reduced 98.08%
775 $18.6 Million
Q2 2018

Mar 24, 2023
BUY
$11.6 - $19.27 $3,503 - $5,819
302 Added 4.74%
6,677 $128 Million
Q1 2018

Mar 24, 2023
SELL
$11.77 - $16.08 $400,768 - $547,524
-34,050 Reduced 84.23%
6,375 $78.9 Million
Q4 2017

Mar 24, 2023
SELL
$11.86 - $14.08 $474,993 - $563,904
-40,050
375 $4.59 Million

Others Institutions Holding CARA

# of Institutions
84
Shares Held
15.5M
Call Options Held
55K
Put Options Held
500
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.2M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email